NCT05508763View on ClinicalTrials.gov

Personalised Therapeutics @LUMC

Active, not recruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

February 28, 2026

Study Completion Date

October 31, 2026

Conditions
Adverse Drug Reaction
Interventions
GENETIC

Genetic test for 14 pharmacogenes

Genotyping with the Global Diversity Array-8 v1.0 BeadChip with enhanced PGx

Trial Locations (1)

2333ZA

Leiden University Medical Center, Leiden

All Listed Sponsors
collaborator

bio.logis digital health GmbH

UNKNOWN

lead

Leiden University Medical Center

OTHER

NCT05508763 - Personalised Therapeutics @LUMC | Biotech Hunter | Biotech Hunter